Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News
Vom Explorer zur Gelddruckmaschine? Dieser Goldwert zündet gerade die nächste Stufe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL7T | ISIN: SE0017769995 | Ticker-Symbol: BGLA
Tradegate
13.05.26 | 19:55
12,170 Euro
+0,25 % +0,030
1-Jahres-Chart
BIOGAIA AB Chart 1 Jahr
5-Tage-Chart
BIOGAIA AB 5-Tage-Chart
RealtimeGeldBriefZeit
12,11012,21010:24
12,11012,21010:24

Aktuelle News zur BIOGAIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
MoProbiotika-Aktie BioGaia nähert sich Allzeithoch2
FrDividendenbekanntmachungen (08.05.2026)13.233 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1057 EUR  ADIDAS AG  DE000A1EWWW0 - 2,8 EUR  ALLIANCE RESOURCE PARTNERS LP  US01877R1086  0...
► Artikel lesen
07.05.BioGaia AB: Bulletin from Annual General Meeting of BioGaia AB (publ)115The Annual General Meeting of BioGaia AB (publ) was held on 7 May 2026 at 4.00 pm at Klara Konferens & Happynings, Klarabergsviadukten 90, Stockholm, at which the shareholders passed the resolutions...
► Artikel lesen
07.05.BioGaia AB Ser. B Reveals Drop In Q1 Income2
BIOGAIA Aktie jetzt für 0€ handeln
07.05.BioGaia AB launches BioGaia Protectis Plus - next-generation patented probiotic drops2
07.05.BioGaia AB: Interim Management Statement January - March 2026145FIRST QUARTER 2026 Net sales amounted to SEK 372.6 million (366.3), an increase of SEK 6.3 million, an increase excluding currency effects of 15% (2% including currency effects). Net sales in the...
► Artikel lesen
30.04.Invitation to media and analyst briefing for BioGaia Q1 2026 report2
28.04.BioGaia AB research confirms effectiveness of patented LongevityGuard technology in extending probiotic shelf life210Researchers at BioGaia have published new scientific findings in the journal Food and Bioprocess Technology, demonstrating that BioGaia's patented LongevityGuard® technology significantly improves the...
► Artikel lesen
30.03.Notice to attend the Annual General Meeting of BioGaia AB (publ)1
30.03.BioGaia Annual and Sustainability Report 2025 published3
20.03.BIOGAIA: 10-year follow-up study shows infant probiotics are positively associated with a reduction of childhood functional abdominal pain2
17.03.BioGaia AB: BioGaia exercises option to acquire remaining shares in Nutraceutics240BioGaia exercises the option to acquire the remaining 20 percent of the shares in Nutraceutics, the parent company to BioGaia's exclusive distributor of BioGaia's own products in the USA. BioGaia...
► Artikel lesen
26.02.BioGaia AB extends long-standing distribution partnership with Ewopharma200BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies' successful collaboration to date and reflects a shared ambition...
► Artikel lesen
18.02.Probiotikahersteller BioGaia wächst weiter6
12.02.BioGaia AB Ser. B Bottom Line Rises In Q4-
12.02.BioGaia AB: Year-end report January - December 2025234FOURTH QUARTER 2025 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified.) Net sales amounted to SEK 440.6 million (364.8), an increase of SEK 75.7 million...
► Artikel lesen
03.02.BioGaia AB: BioGaia's results for the fourth quarter to exceed market expectations210(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2025, BioGaia's sales were positively affected by quarterly variations for individual orders of approximately...
► Artikel lesen
02.02.Invitation to media and analyst briefing for BioGaia Q4 2025 report2
03.12.25Neues Design, neue Produkte: BioGaia wird erwachsen4
28.10.25BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production365Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1